Board Appraisals - From Compliance to Success


Many organisations approach board appraisal as something difficult and boring, but, it doesn’t have to be that way. A successful board appraisal can not only be interesting, but also add significant value to an organisation by helping poor-performing boards sort out problems and the better ones get better.

An unsuccessful appraisal can at best be a waste of valuable time, at worst destructive. This article by Professor Sir Andrew Likierman, the Dean of London Business School, explores the basis for measuring that success.

The article includes comments from Peter Waine, a Criticaleye Associate and Partner at Hanson Green.

Share this with your Community



Contributor
Peter Waine
Board Mentor
Criticaleye


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Mike Maudsley, CEO of enfinium: How Great CEOs Stay Ahead of the Curve

Mike Maudsley, CEO of enfinium, joins Bridgette Hall, Senior Editor at Criticaleye, to explore what it takes to succeed as a CEO in today’s fast-changing business environment. As organisations navigate incr...


Click here to download this insight

Employee Happiness in the Age of AI

In this report, AlixPartners and Darwin X argue that retail consistently trails other industries on employee happiness, and that closing that gap is not just a people issue, but a prerequisite for competing in the ag...


Click here to download this insight

VIEWPOINTS | Making the Leap from CPO to NED

Tea Colaianni MBE's career began in Brussels as a lawyer before deciding  she wanted to be in the driving seat. "I didn't want just to be advising companies on what to do: I wanted to do stuff,...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 200




London Stock Exchange Group Canaccord Genuity Group Inc British Land Global Payments Lightsource bp Stream NatWest Group CrowdStrike NATS E.ON UK Rolls-Royce Hitachi Solutions LACE Partners Southern Water AlixPartners Legal & General Aldermore Group Drax Group plc Mayborn Group GlaxoSmithKline plc